Advertisement

 

 

QUIT EMR trial: a prospective, observational, multicentre study to evaluate quality and 24 hours post-transport morbidity of interhospital transportation of critically ill patients: study protocol.

QUIT EMR trial: a prospective, observational, multicentre study to evaluate quality and 24 hours post-transport morbidity of interhospital transportation of critically ill patients: study protocol.
Author Information (click to view)

Strauch U, Bergmans DC, Habers J, Jansen J, Winkens B, Veldman DJ, Roekaerts PM, Beckers SK,


Strauch U, Bergmans DC, Habers J, Jansen J, Winkens B, Veldman DJ, Roekaerts PM, Beckers SK, (click to view)

Strauch U, Bergmans DC, Habers J, Jansen J, Winkens B, Veldman DJ, Roekaerts PM, Beckers SK,

Advertisement

BMJ open 2017 03 107(3) e012861 doi 10.1136/bmjopen-2016-012861
Abstract
INTRODUCTION
It is widely accepted that transportation of critically ill patients is high risk. Unfortunately, however, there are currently no evidence-based criteria with which to determine the quality of various interhospital transport systems and their impact on the outcomes for patients. We aim to rectify this by assessing 2 scores which were developed in our hospital in a prospective, observational study. Primarily, we will be examining the Quality of interhospital critical care transportation in the Euregion Meuse-Rhine (QUIT EMR) score, which focuses on the quality of the transport system, and secondarily the SEMROS (Simplified EMR outcome score) which detects changes in the patient’s clinical condition in the 24 hours following their transportation.

METHODS AND ANALYSIS
A web-based application will be used to document around 150 pretransport, intratransport and post-transport items of each patient case.To be included, patients must be at least 18-years of age and should have been supervised by a physician during an interhospital transport which was started in the study region.The quality of the QUIT EMR score will be assessed by comparing 3 predefined levels of transport facilities: the high, medium and low standards. Subsequently, SEMROS will be used to determine the effect of transport quality on the morbidity 24 hours after transportation.It is estimated that there will be roughly 3000 appropriate cases suitable for inclusion in this study per year. Cases shall be collected from 1 April 2015 until 31 December 2017.

ETHICS AND DISSEMINATION
This trial was approved by the Ethics committees of the university hospitals of Maastricht (Netherlands) and Aachen (Germany). The study results will be published in a peer reviewed journal. Results of this study will determine if a prospective randomised trial involving patients of various categories being randomly assigned to different levels of transportation system shall be conducted.

TRIAL REGISTRATION NUMBER
NTR4937.

Submit a Comment

Your email address will not be published. Required fields are marked *

4 × 4 =

[ HIDE/SHOW ]